ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer.

Bradley J MonkRobert L ColemanKeiichi FujiwaraMichelle K WilsonAmit M OzaAna OakninDavid M O'MalleyDomenica LorussoShannon Neville WestinTamar SafraThomas J HerzogFrederik MarméRamez N EskanderKevin K LinDanny ShihSandra GobleNikolay GrechkoStephanie HumeLara MaloneyIain A McNeishRebecca S Kristeleit

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)

This trial is registered at clinicaltrials.gov (NCT03522246).

Keyphrases

phase iii
open label
clinical trial
phase ii
double blind
placebo controlled
combination therapy
study protocol
locally advanced
randomized controlled trial
radiation therapy